Dr. Melissa Dawn Lah, MD
- Part D claims, 2024
- 36
- Publications
- 18
- Clinical trials
- 4
- Hospital affiliations
- 1
- Industry payments
- $133,685
- Practice address
- 1701 N Senate Blvd, Indianapolis, IN 46202
- Practice phone
- Call (317) 962-2000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Lah's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Melissa Dawn Lah is a clinical molecular genetics physician in Indianapolis, Indiana
Dr. Lah practices at IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health.
Dr. Lah's NPI, 1962607820, was assigned on June 19, 2007. Dr. Lah graduated from Indiana University School Of Medicine in 2007. Dr. Lah's Indiana license number on file is 01068482A.
- NPI
- 1962607820NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2264698356
- NPI enumeration date
- June 19, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (317) 962-2000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 45
- Medical school graduation
- 2007
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Melissa Dawn Lah practices at IU Health Methodist Hospital in Indianapolis, Indiana
Dr. Lah's primary practice is IU Health Methodist Hospital, at 1701 N Senate Blvd, Indianapolis, IN 46202 in Marion County. The practice phone is (317) 962-2000.
- IU Health Methodist Hospital1701 N Senate Blvd, Indianapolis, IN 46202 · Marion CountyPhone(317) 962-2000
Source: Dmand AI Affiliation Data
Dr. Melissa Dawn Lah is affiliated with 4 sites of care and 3 medical groups
Dr. Lah's primary practice is IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Lah to 2 more medical groups, 1 behavioral health center, 1 community health center and 1 group practice or clinic, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Melissa Dawn Lah's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lah practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| IU Health Methodist Hospital | Available with a free account |
| +3 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Indiana University Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Melissa Dawn Lah is one of 4 clinical molecular genetics physicians in Indiana
Clinical molecular genetics is Dr. Lah's primary specialty in the NPI Registry, under taxonomy code 207SG0203X. Dr. Lah is board certified in clinical genetics and genomics by the American Board of Medical Genetics and Genomics. Dr. Lah has a license on file in Indiana.
Specialties and state licenses
- Clinical molecular genetics, IndianaPrimary
Clinical molecular genetics physicians near Dr. Lah
Counts of clinical molecular genetics physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Melissa Dawn Lah's patients have a median age of 13
Across all payers, Dmand AI patient panel data puts Dr. Lah's median patient age at 13, with 51% women.
Dr. Lah's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 13
Patient panel by sex, all payers
- Women51%
- Men48%
Source: Dmand AI Patient Panel Data
Dr. Melissa Dawn Lah wrote 36 Medicare Part D claims in 2024
In 2024, Dr. Lah wrote 36 Medicare Part D claims. 61% of them were for generic drugs. CMS names the drug for 33 of them, across 2 drugs with 11 or more claims each, at $968,788 in total drug cost. In 2022, CMS named 12 claims across 1 drug.
Dr. Lah's Part D claims by kind of drug, 2024
- Generic22 claims61%
- Brand-name14 claims39%
Dr. Lah's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2022 to 2024
- 2022
- 2024
- Claims for drugs CMS names
- 2022: 122024: 33175%
Drugs named by CMS: 2 in 2024, 1 in 2022.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Melissa Dawn Lah takes part in Medicare
Dr. Lah accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Melissa Dawn Lah has 18 publications on record
Dmand AI links 18 papers to Dr. Lah, published from 2015 to 2024. 2018 was the busiest year, with 4. The most frequent topics are Phenotype, Abnormalities, Multiple and Genetic Testing. Dr. Lah has published most often in Am J Med Genet A. Dr. Lah's most frequent co-authors are David D. Weaver, MD, Hans C. Andersson, MD and Molly Anne McPheron, MD.
Dr. Lah's papers by year, 2015 to 2024
Topics Dr. Lah writes about most
- Phenotype
- Abnormalities, Multiple
- Genetic Testing
- Diazoxide
- Hyperphagia
- Phenylalanine
- Phenylalanine Ammonia-Lyase
- Phenylketonurias
Dr. Lah's most frequent co-authors
- David D. Weaver, MD4 shared papers
- Hans C. Andersson, MD3 shared papers
- Molly Anne McPheron, MD3 shared papers
Recent publications by Dr. Lah
Am J Hum Genet
Mol Genet Metab
Obesity (Silver Spring)
See who Dr. Lah researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lah works with, so you can find a warm path to the right clinical molecular genetics physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Melissa Dawn Lah has worked on 4 clinical trials
Dmand AI links Dr. Lah to 4 clinical trials, 3 of them phase 3 studies. Conditions studied include Prader-Willi Syndrome, Imprinting Disorders and Muscle Weakness. Soleno Therapeutics, Inc. sponsors the most, 2.
Conditions in Dr. Lah's trials
- Prader-Willi Syndrome
- Imprinting Disorders
- Muscle Weakness
- Phenylketonurias
- Amino Acid Metabolism, Inborn Errors
Investigators on the most trials with Dr. Lah
- Eric Felner, MD2 shared trials
- Amy D. Fleischman, MD2 shared trials
- Lori-Anne Patricia Schillaci, MD2 shared trials
Recent clinical trials with Dr. Lah
A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Melissa Dawn Lah received $133,685 in industry payments from 2016 to 2025
CMS Open Payments shows 174 general payments to Dr. Lah from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 38% of the total. BioMarin Pharmaceutical Inc. paid the most, $68,232.
General payments to Dr. Lah by program year, 2016 to 2025
General payments to Dr. Lah by kind, 2016 to 2025
- Consulting fees$51,15938%
- Speaker and faculty fees$39,79130%
- Travel and lodging$31,48024%
- Food and beverage$5,4264%
- Other$5,8284%
Companies that paid Dr. Lah the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Melissa Dawn Lah graduated from Indiana University School Of Medicine
Dr. Lah graduated from Indiana University School Of Medicine in 2007. Dr. Lah is a member of AAP, American College of Medical Genetics and Genomics, AMA, AMWA, American Society of Human Genetics and Indiana State Medical Association.
- Medical school
- Board certified in clinical genetics and genomics
- Board certified in pediatrics
Source: Dmand AI Professional Profile Data
Dr. Melissa Dawn Lah accepts plans from 12 insurance carriers
Dr. Lah is in network with 12 carriers, including United Healthcare, Elevance and Aetna. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.
- United Healthcare
- Elevance
- Aetna
- Blue Cross Blue Shield of Michigan
- HCSC
- Alliant Health Plans
- Aspirus Health Plan
- Blue Cross and Blue Shield of Kansas City
- +4 more carriersWith a free account
Plan types Dr. Lah accepts, by number of carriers
- HMO7
- PPO7
- EPO3
- Medicare2
- POS1
Source: Dmand AI Insurance Network Data
Sources for Dr. Melissa Dawn Lah's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Melissa Dawn Lah
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Melissa Dawn Lah's NPI number?
Dr. Melissa Dawn Lah's NPI number is 1962607820. It was assigned on June 19, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Melissa Dawn Lah?
Dr. Melissa Dawn Lah is a clinical molecular genetics physician in Indianapolis, Indiana. The primary specialty in the NPI Registry is Clinical Molecular Genetics Physician (taxonomy code 207SG0203X).
Where does Dr. Melissa Dawn Lah practice?
Dr. Lah practices at 1701 N Senate Blvd, Indianapolis, IN 46202. Dr. Lah's primary practice is IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health. Dmand AI also links Dr. Lah to 2 medical groups, 1 behavioral health center, 1 community health center and 1 group practice or clinic.
What is Dr. Melissa Dawn Lah's office phone number?
The practice phone on file for Dr. Lah is (317) 962-2000.
What is Dr. Melissa Dawn Lah's medical license number?
Dr. Lah's Indiana license number on file is 01068482A.
Which hospitals is Dr. Melissa Dawn Lah affiliated with?
Dr. Lah practices at IU Health Methodist Hospital in Indianapolis, Indiana.
What medical group is Dr. Melissa Dawn Lah part of?
Dr. Lah is linked to IU Health Medical Group. Dmand AI links Dr. Lah to 2 more medical groups.
Does Dr. Melissa Dawn Lah accept Medicare?
Yes. CMS lists Dr. Lah as accepting Medicare assignment.
Is Dr. Melissa Dawn Lah board certified?
Yes. Dr. Lah is board certified in clinical genetics and genomics by the American Board of Medical Genetics and Genomics.
Where did Dr. Melissa Dawn Lah go to medical school?
Dr. Lah graduated from Indiana University School Of Medicine in 2007.
Show 6 more questionsShow fewer questions
What drugs does Dr. Melissa Dawn Lah prescribe most?
In 2024 Medicare Part D data, Dr. Lah's most prescribed drugs by claims were Javygtor and Palynziq.
Has Dr. Melissa Dawn Lah received payments from drug or device companies?
CMS Open Payments shows $133,685 in general payments to Dr. Lah from 10 companies from 2016 to 2025. The largest total came from BioMarin Pharmaceutical Inc.
How long has Dr. Melissa Dawn Lah been practicing?
Dr. Lah graduated from medical school in 2007, 19 years ago.
Does Dr. Melissa Dawn Lah do research?
Dmand AI links 18 publications to Dr. Lah, published from 2015 to 2024. Dr. Lah has worked on 4 clinical trials.
Who does Dr. Melissa Dawn Lah publish with?
Dr. Lah's most frequent co-authors are David D. Weaver, MD (4 shared papers), Hans C. Andersson, MD (3 shared papers) and Molly Anne McPheron, MD (3 shared papers).
What insurance does Dr. Melissa Dawn Lah accept?
Dr. Lah is in network with 12 carriers, including United Healthcare, Elevance and Aetna. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.
Selling to clinical molecular genetics practices?
See clinical molecular genetics physicians in Indiana by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card